Modifications of mammalian cells using artificial micro-RNA to alter their properties and the compositions of their products
US11162102B2 · kind B2 · utility
9Cited by
0References
24Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | May 11, 2020 |
| Grant date | Nov 2, 2021 |
| Priority date | — |
| Expiry date | May 11, 2040 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12Y603/01002
- WIPO fieldBiotechnology
- WIPO sectorChemistry
Abstract
The present invention provides methods and compositions for stable genetic modification of cultured mammalian cells. The genetic modifications can be used to produce cultured mammalian cells for therapeutic or diagnostic purposes.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.